Literature DB >> 12885423

Serum-derived factors weaken the barrier properties of cultured porcine brain capillary endothelial cells in vitro.

Thorsten Nitz1, Tanja Eisenblätter, Katherina Psathaki, Hans-Joachim Galla.   

Abstract

Cultured cerebral capillary endothelial cells are often used as a functional in vitro model of the blood-brain barrier (BBB) to determine drug uptake or to study barrier properties. Usually serum is supplemented to these cultures for cell proliferation. Here, we demonstrate the effect of serum and the serum-derived factors lysophosphatidic acid (LPA) and vascular endothelial growth factor (VEGF) on the barrier properties of cultured porcine brain capillary endothelial cells (PBCEC). Serum prevents tight junction formation of confluent PBCEC monolayers and moreover, opens already established tight junctions shown by decreasing transendothelial electrical resistances (TER). These effects are highly polarised with serum almost exclusively acting from the basolateral side of the cell culture. Immunocytochemistry of PBCEC revealed a delocalisation of the cell border lining tight junction proteins ZO-1, occludin and claudin-5 when serum was added. A serum fraction of 67 kDa was isolated by size-exclusion chromatography, identified as albumin and found to cause a serum-like decrease of the TER. However, fatty acid-free serum albumin does not develop this barrier weakening effect, indicating that small protein-bound factors might be responsible. For instance, serum-bound LPA demonstrated a TER-decreasing effect as well, but in contrast to serum mainly when added to the apical side of PBCEC. Addition of VEGF caused a serum-like decrease of the TER with the same polar effect; however, VEGF will be denatured by heat and could thus not be the heat-sensitive factor. Thus, we hypothesise that serum contains a variety of factors which weaken the tightness of a PBCEC monolayer from the apical side as expected but also from the basolateral side. Although the structure of the 67 kDa factor could not be analysed, this finding is of importance for in vitro models not only of the blood-brain barrier mostly using serum-containing media.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885423     DOI: 10.1016/s0006-8993(03)02834-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

1.  Influence of hydrocortisone on the mechanical properties of the cerebral endothelium in vitro.

Authors:  Sebastian Schrot; Christian Weidenfeller; Tilman E Schäffer; Horst Robenek; Hans-Joachim Galla
Journal:  Biophys J       Date:  2005-09-23       Impact factor: 4.033

Review 2.  Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology.

Authors:  Máiria A Deli; Csongor S Abrahám; Yasufumi Kataoka; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

3.  Dabigatran abrogates brain endothelial cell permeability in response to thrombin.

Authors:  Brian Thomas Hawkins; Yu-Huan Gu; Yoshikane Izawa; Gregory John del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

Review 4.  Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors:  Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

5.  Role of vasodilator stimulated phosphoprotein in VEGF induced blood-brain barrier permeability in endothelial cell monolayers.

Authors:  Brandon Davis; Jun Tang; Li Zhang; Dezhi Mu; Xiangning Jiang; Valerie Biran; Zinaida Vexler; Donna M Ferriero
Journal:  Int J Dev Neurosci       Date:  2010-06-30       Impact factor: 2.457

Review 6.  Mechanosensing at the vascular interface.

Authors:  John M Tarbell; Scott I Simon; Fitz-Roy E Curry
Journal:  Annu Rev Biomed Eng       Date:  2014-06-02       Impact factor: 9.590

Review 7.  TEER measurement techniques for in vitro barrier model systems.

Authors:  Balaji Srinivasan; Aditya Reddy Kolli; Mandy Brigitte Esch; Hasan Erbil Abaci; Michael L Shuler; James J Hickman
Journal:  J Lab Autom       Date:  2015-01-13

8.  Rapid and reversible enhancement of blood-brain barrier permeability using lysophosphatidic acid.

Authors:  Ngoc H On; Sanjot Savant; Myron Toews; Donald W Miller
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-18       Impact factor: 6.200

9.  Cilostazol strengthens barrier integrity in brain endothelial cells.

Authors:  Shoji Horai; Shinsuke Nakagawa; Kunihiko Tanaka; Yoichi Morofuji; Pierre-Oliver Couraud; Maria A Deli; Masaki Ozawa; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.046

Review 10.  Lysophosphatidic acid in vascular development and disease.

Authors:  Siew T Teo; Yun C Yung; Deron R Herr; Jerold Chun
Journal:  IUBMB Life       Date:  2009-08       Impact factor: 3.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.